Blue Oak Pharmaceuticals

About:

Blue Oak Pharmaceuticals is a pharmaceutical company that is committed to finding the next generation of drugs for brain disorders.

Website: http://blueoakpharma.com/

Top Investors: Viva BioInnovator, ShangPharma Innovation, Viva Ventures Biotech Fund

Description:

Blue Oak Pharmaceuticals is a pharmaceutical company that is committed to finding the next generation of drugs for brain disorders. They believe that first-in-class drugs will be discovered by integrating novel, custom-designed privileged chemotypes with validated in vivo systems neurobiology assays and brain circuit imaging. Blue Oak drug hunters are experts in the systems neurobiology of brain disorders, medicinal chemistry, and informatics. Their productivity integrates a “global research team” that integrates established partners with cutting-edge technologies in behavioral profiling, synthetic chemistry, and brain imaging. They advance first-in-class clinical candidates to early phase proof-of-concept studies using translational medicine biomarkers for brain circuit activity. It was founded in 2016 and is headquartered in Waltham, Massachusetts.

Total Funding Amount:

$10.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2016-01-01

Founders:

Kerry Spear, Tom Large

Number of Employees:

1-10

Last Funding Date:

2021-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai